Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Innoviva, Inc.(INVA) | 7,277,000 | 7,277,000 | 0 | $119.34M | $140.52M | 34.93% | +$21.18M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $106.86M | $67.53M | 16.78% | -$39.34M |
| Gilead Sciences, Inc.(GILD) | 1,103,282 | 763,333 | -339,949 | $75.70M | $64.00M | 15.91% | -$11.70M |
| Cytokinetics, Incorporated(CYTK) | 1,110,000 | 1,110,000 | 0 | $60.14M | $58.61M | 14.57% | -$1.53M |
| Neurocrine Biosciences, Inc.(NBIX) | 410,483 | 410,483 | 0 | $56.51M | $47.30M | 11.76% | -$9.22M |
| Amarin Corp PlcADR | 24,850,623 | 24,850,623 | 0 | $17.10M | $15.58M | 3.87% | -$1.52M |
| Biogen Inc.(BIIB) | 643,000 | 26,950 | -616,050 | $149.06M | $5.22M | 1.30% | -$143.84M |
| Lantheus Holdings, Inc.(LNTH) | 0 | 26,000 | +26,000 | $0 | $2.85M | 0.71% | +$2.85M |
| Vor Biopharma Inc.(VOR) | 618,000 | 618,000 | 0 | $618.0K | $432.6K | 0.11% | -$185.4K |
| Regulus Therapeutics Inc | 185,183 | 185,183 | 0 | $330.6K | $290.7K | 0.07% | -$39.8K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,094,168 | 0 | -1,094,168 | $6.76M | $0 | — | -$6.76M |